Overview

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

Status:
Completed

Trial end date:
2001-02-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to compare the effectiveness of an oral formulation of risperidone (an antipsychotic medication) to that of placebo for treating behavioral and psychological signs and symptoms in dementia (BPSSD), specifically aggression, delusions, and hallucinations, in patients with dementia.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen-Cilag Pty Ltd

Treatments:

Risperidone